SGT-263

Introduction

SGT-263 is a synthetic cannabinoid that belongs to the indazole family. It is a potent agonist of the CB1 receptor and has been used for research purposes. The chemical structure of SGT-263 is similar to other synthetic cannabinoids, such as JWH-018 and AB-CHMINACA. However, SGT-263 is known to be more potent and has a longer duration of action.

Chemical Properties

SGT-263 has the chemical formula C₂₂H₂₇N₃O₃F and a molecular weight of 395.5 g/mol. It has a melting point of 95-98°C and is soluble in organic solvents such as ethanol and acetone. SGT-263 is usually supplied as a white or off-white powder.

Pharmacology

SGT-263 is a potent agonist of the CB1 receptor, which is responsible for the psychoactive effects of cannabis. It has been found to have a higher binding affinity for the CB1 receptor compared to other synthetic cannabinoids such as JWH-018 and AB-CHMINACA. SGT-263 has also been shown to have a longer duration of action compared to other synthetic cannabinoids, with effects lasting up to 8 hours.

Uses

SGT-263 is primarily used for research purposes. It has been used in studies to investigate the effects of synthetic cannabinoids on the CB1 receptor and their potential use as therapeutic agents. SGT-263 has also been used in forensic toxicology to detect synthetic cannabinoids in biological samples.

Side Effects

The use of SGT-263 has been associated with several side effects. These include anxiety, paranoia, hallucinations, and tachycardia. Other reported side effects include nausea, vomiting, and respiratory depression. Long-term use of SGT-263 may also lead to addiction and withdrawal symptoms.

Legal Status

SGT-263 is a Schedule I controlled substance in the United States. It is also illegal in several other countries, including Sweden, where it is classified as a hazardous substance. The possession, distribution, and sale of SGT-263 may result in legal penalties.

Conclusion

In conclusion, SGT-263 is a synthetic cannabinoid that has been used for research purposes. It is a potent agonist of the CB1 receptor and has a longer duration of action compared to other synthetic cannabinoids. However, its use has been associated with several side effects and is illegal in several countries, including the United States and Sweden. It is important to use caution when handling SGT-263 and to follow all applicable laws and regulations.